CompletedNot Applicable

Early Versus Late Use of Hi-VNI in Covid-19

Egypt30 participantsStarted 2021-10-01

Plain-language summary

This study evaluate early administration of high-velocity nasal insufflation in COVID-19 patients presented with acute respiratory failure after failure of conventional low flow nasal cannula bypassing the escalating step of Non re-breathing mask where early use of High velocity nasal insufflations achieved better improvement of respiratory distress, lower oxygen requirements and shorter ICU stay.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Non severe COVID Patients
✕. Patients with comorbidities (e.g chronic chest dis, DM, renal failure and hepatic failure
✕. Patients indicated for mechanical ventilation
✕. Patients with marked hypercapnia in need for non-invasive ventilation

What they're measuring

Improved oxygenation

Timeframe: through the study completion, average 6 months

Trial details

NCT IDNCT05663138

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02-28

View on ClinicalTrials.gov More COVID-19 trials